With regard to his background, Dr. Lin has served as Chief of Vascular
Surgery at Baylor College of Medicine before moving to LA in July 2015.
He is a board-certified vascular surgeon specializing in all aspects of
vascular treatment of arterial and venous disorders. He is currently professor
emeritus of surgery at Baylor College of Medicine, and also a Fellow of
the American College of Surgery.
Dr. Lin served as a full-time surgical faculty of the Michael E. DeBakey
Department of Surgery at Baylor College of Medicine, Houston, Texas from
2001 to 2015. He was appointed as the Chief of Vascular Surgery at Baylor
College of Medicine from 2006 to 2015. He also served as the chief of
vascular surgery at the Michael E. DeBakey VA Medical Center from 2001
to 2007, where he transformed its vascular program into a premier clinical
service in the VA healthcare system. The remarkable success of this clinical
program subsequently led to the visit of President George H.W. Bush in 2003.
Dr. Lin has also served as a physician advisor to Congressman Gene Green
who introduced Aneurysm Detection Bill in 2004 which provided Medicare
coverage for Abdominal Aortic Aneurysm (AAA) screening and detection.
The legislation became known as the Screening Abdominal Aortic Aneurysms
Very Efficiently (SAAAVE) Act of 2004 (HR 4626).
Dr. Lin is active in both patient care and research. He has been involved
in multiple clinical trials investigating endovascular treatment modalities
in aortic aneurysm and carotid artery stenting. He has developed an active
research program in clinical and basic science that includes several research
grants funded by the National Institutes of Health to study the molecular
pathogenesis of peripheral arterial occlusive disease.
He presents his work regularly at national and international meetings and
symposia. His writing and presentations have focused on a range of subjects
including endovascular treatment of aortic aneurysms, thrombolytic therapy
for deep vein thrombosis and pulmonary embolism, endovascular treatment
of lower extremity occlusive disease, experimental models of endovascular
therapy, and thrombolysis in arterial and venous thrombosis research.
Dr. Lin has published more than 400 scholarly articles in the fields of
vascular surgery and endovascular therapy. He has authored more than 60
book chapters and edited 3 vascular textbooks. He serves on the editorial
boards or as a reviewer for many prestigious journals. His publications
have appeared in New England Journal of Medicine, Journal of Vascular
Surgery, Journal of Cardiovascular Surgery, and many other prestigious journals.
A native of Taiwan, Dr. Lin speaks fluent Mandarin. He grew up in southern
California, and received a bachelor’s degree in biology from the
University of California, Riverside. He received his medical degree from
Finch University of Health Science in North Chicago. He completed his
surgical residency at Mt. Sinai Medical Center in Chicago, and vascular
fellowship at the Emory University School of Medicine in Atlanta, GA.
As an academic physician, he has demonstrated a life-long commitment to
teaching, and has mentored many medical students, surgical residents,
and young faculty. He has been recognized eight times with the Outstanding
Faculty Teaching Award at Baylor College of Medicine. His remarkable clinical
skills and patient care have also been recognized by his colleagues as
one of the Best Doctors in America. He has also been named among the top
1% of vascular surgeons by U.S. News & World Report.